4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000138
EVP, Chief Commercial Officer sold 2,633 shares at $498.42 ($1,312,340)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
McKechnie Duncan · EVP, Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-11 | Sale : show line 1 in the form 10b5-1 | −2,633 | $498.42 | $1,312,340 | 12,489 | D |
| Open-market sales · 2,633 sh · avg $498.42 · $1,312,340 | ||||||
Loading xslF345X05/wk-form4_1773432707.xml…